Comparison between Earum Pharmaceuticals IPO and Wonder Fibromats IPO.
Earum Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Wonder Fibromats IPO is a SME Fixed Price proposed to list at NSE SME.
| Earum Pharmaceuticals IPO | Wonder Fibromats IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Hem Securities Ltd. | Navigant Corporate Advisors Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Hem Securities Ltd. | Bhaijee Portfolio Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the Wonder Fibromats IPO is up to ₹18.80 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of Wonder Fibromats IPO is ₹89.00 per share.
| Earum Pharmaceuticals IPO | Wonder Fibromats IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹36.00 per share | ₹89.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 17,52,000 shares | 21,12,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.31 Cr | up to ₹18.80 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,52,000 shares | 21,12,000 shares |
| Issue Size Total (Amount) | up to ₹6.31 Cr | up to ₹18.80 Cr |
Earum Pharmaceuticals IPO opens on Jun 21, 2019, while Wonder Fibromats IPO opens on Jul 22, 2019. The closing date of Earum Pharmaceuticals IPO and Wonder Fibromats IPO is Jun 26, 2019, and Jul 29, 2019, respectively.
| Earum Pharmaceuticals IPO | Wonder Fibromats IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 21, 2019 | Jul 22, 2019 |
| Issue Close | Jun 26, 2019 | Jul 29, 2019 |
| Basis Of Allotment (Tentative) | Jul 01, 2019 | Jul 29, 2019 |
| Initiation of Refunds (Tentative) | Jul 02, 2019 | Jul 30, 2019 |
| Credit of Share (Tentative) | Jul 03, 2019 | Jul 31, 2019 |
| Listing date (Tentative) | Jul 04, 2019 | Aug 06, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Earum Pharmaceuticals IPO P/E ratio is , as compared to Wonder Fibromats IPO P/E ratio of .
| Earum Pharmaceuticals IPO | Wonder Fibromats IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 97.75 | ||||
| Promoter Shareholding (Post-Issue) | 70.04 | 71.79 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹22.20 Cr. | ₹74.54 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in Wonder Fibromats IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in Wonder Fibromats IPO.
| Earum Pharmaceuticals IPO | Wonder Fibromats IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 96,000 shares | 1,12,000 shares |
| QIB | ||
| NII | 8,76,000 shares | 10,56,000 shares |
| RII | 8,76,000 shares | 10,56,000 shares |
| Employee | ||
| Others | ||
| Total | 17,52,000 shares | 21,12,000 shares |
Earum Pharmaceuticals IPO subscribed 1.60x in total, whereas Wonder Fibromats IPO subscribed 1.26x.
| Earum Pharmaceuticals IPO | Wonder Fibromats IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.72x | 2.19x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.48x | 0.33x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.60x | 1.26x |
